[Strict additivity of the antispasmodic effects of papaverine and tiemonium: an example of sequential blockage].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 145278)

Published in C R Seances Soc Biol Fil on January 01, 1977

Authors

C Labrid, G Dureng, H Bert

Articles by these authors

Some membrane interactions with bepridil, a new antianginal agent. J Pharmacol Exp Ther (1979) 1.13

Studies on the bradycardia induced by bepridil. Br J Pharmacol (1982) 0.97

New substituted 1,4-benzoxazine derivatives with potential intracellular calcium activity. J Med Chem (1998) 0.96

Pharmacological evidence for cardiac muscarinic receptor subtypes. Life Sci (1984) 0.89

[Comparative study of various inhibitors of immunologically induced joint edema in the quinea pig]. Therapie (1974) 0.81

Activity of bepridil and other anti-anginals on cardiovascular modifications engendered by conditioned anxiety in the dog. Arch Int Pharmacodyn Ther (1978) 0.81

Daflon as a cellular antioxidant and a membrane-stabilizing agent in human fibroblasts irradiated by ultraviolet A radiation. Photodermatol Photoimmunol Photomed (1991) 0.80

Comparative antidysrhythmic profiles of bepridil, amiodarone and disopyramide in the guinea-pig and dog. Arch Int Pharmacodyn Ther (1981) 0.80

Dualist or pseudo-dualist interactions of mepyramine, diphenhydramine and eprozinol with histamine at H1-receptors. Jpn J Pharmacol (1977) 0.80

[Some pharmacodynamical properties of niaprazine, a new antihistaminic agent]. Therapie (1972) 0.79

[Cardiovascular effects of elliptinium. The mechanism of action]. J Pharmacol (1984) 0.79

Effects of bepridil and of its quaternary derivative on rat tail artery. Eur J Pharmacol (1986) 0.79

[Prolongation of the effective refractory period on isolated guinea pig atria by some anti-arrhythmia agents: relevance in a comparison of their potentialities]. C R Seances Soc Biol Fil (1979) 0.78

Effect of chronic treatment with a purified flavonoid fraction on inflammatory granuloma in the rat. Study of prostaglandin E2 and F2 alpha and thromboxane B2 release and histological changes. Arzneimittelforschung (1987) 0.78

[Bepridil, a functional antagonist of beta1-adrenergic stimulation. Dissociated effects on cardiostimulation and lipolysis. (author's transl)]. J Pharmacol (1981) 0.78

Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats. Am J Cardiol (1988) 0.77

Electrophysiologic effects of bepridil in the anesthetized dog studied by endocardiac electrodes. Am J Cardiol (1984) 0.77

[Cellular disorders induced by ischemia. The effect of trimetazidine]. Presse Med (1986) 0.77

[Interaction of N-methyl and N-butyl scopolammonium and some parasympathomimetics on cholinergic receptors in the jejunum of the rat]. Arch Int Pharmacodyn Ther (1974) 0.75

[The almitrine dimesylate molecule. Various structure-activity relationship aspects]. Presse Med (1984) 0.75

Mechanisms of anti-bronchoconstrictive effects of eprozinol. I. In vitro studies. Pharmacology (1981) 0.75

Activity of a lyophilised whole extract of lamb gastric mucosa in several experimental models of digestive pathology in the rat, the dog and the monkey. Arzneimittelforschung (1977) 0.75

[Comparaison, in the mouse, of two treatments for alcohol withdrawal syndrome. Inhibition of oxo tremorine-induced tremor, sedative and motor effects (author's transl)]. Ann Pharm Fr (1979) 0.75

Bepridil-induced modifications of cardiac performance in the anesthetized dog: comparison with nitroglycerin and propranolol. Arch Int Pharmacodyn Ther (1982) 0.75

Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis. Arzneimittelforschung (1975) 0.75

Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. III. Action on the secretions of the digestive tract and on the central nervous system, acute toxicity. Arzneimittelforschung (1975) 0.75

Different membrane mechanisms of action for tiemonium; a comparison with atropine and papaverine. Arch Int Pharmacodyn Ther (1976) 0.75

2-Benzodioxinylaminoethanols: a new class of beta-adrenergic blocking and antihypertensive agents. J Med Chem (1981) 0.75

[Morphine self-administration added to food conditioning: methodological variant in rats]. C R Seances Soc Biol Fil (1977) 0.75

[Compared efficacies of somes antispasmodic drugs on the digestive tract and the bladder of the anesthetized dog (author's transl)]. J Pharmacol (1981) 0.75

Changes in gastric secretion induced by a lyophilised whole extract of lamb gastric mucosa. Arzneimittelforschung (1977) 0.75

[Relation between the electronic structure of a series of 1,4-tetrahydro-oxazines and their p-D2, for the tryptaminergic receptor]. C R Acad Sci Hebd Seances Acad Sci D (1978) 0.75

Role of rat-liver alcohol dehydrogenase in the glycerol pathway to L-lactate in homogenates. Arch Int Physiol Biochim (1977) 0.75

[Results of the study of choleresis in rats according to whether the subject is anesthetized, constrained, or in a free situation]. C R Seances Soc Biol Fil (1970) 0.75

[Creation, in the dog, of a denervated antral pouche, associated with a Heindenhain's pouche: technical considerations relative to surgical time and postoperative complications]. C R Seances Soc Biol Fil (1975) 0.75

Almitrine bismesylate: pharmacological review and structure-activity relationships. Eur J Respir Dis Suppl (1983) 0.75

[Benzoxazolinone phenylethanolamine antagonists of adrenergic receptors. A chemical and pharmacodynamic study]. Farmaco Sci (1986) 0.75

[Experimental models in cerebral ischemia: application to the study of duxil]. Rev Med Interne (1988) 0.75

Sugar derivatives of indolamines. Part V : cardiovascular effects and "anti-stress" activity of desoxyfructose derivative of serotonin and 5-methoxy-tryptamine. Thromb Res (1979) 0.75

General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). II. Actions on the cardiovascular system, intestinal transit and central nervous system. Arzneimittelforschung (1976) 0.75

[Value of the "gastric chamber", new technic performed ex vivo, for the study of the gastric mucosa of the rat]. C R Seances Soc Biol Fil (1975) 0.75

[Inhibition, in the rat, of gastric acidity rebound by some vagolytic agents. Comparison of systemic and topical effects]. Biol Gastroenterol (Paris) (1972) 0.75

[Tianeptine, an uncommon psychotropic drug]. Encephale (1989) 0.75

[Comparative effects of choleretic agents in rats according to whether the subject is anesthetized, restrained, in free situation with or without correction of the biliary loss]. C R Seances Soc Biol Fil (1971) 0.75

[Comparative affinity of several standard anti-secretory agents for the intestinal cholinergic receptors of of rats and dogs]. C R Seances Soc Biol Fil (1977) 0.75

Vitamin B12 and a lyophilised extract of lamb gastric mucosa in the treatment of two digestive pathological models in the rat and the dog. Clinical and macroscopical observations. Arzneimittelforschung (1980) 0.75

Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect. Klin Wochenschr (1984) 0.75

[Evaluation of beta-adrenolytic activity. Structure-activity relationship]. Ann Med Interne (Paris) (1987) 0.75

Design and synthesis of substituted compounds containing the 1, 4-benzodioxin subunit. New potential calcium antagonists. Eur J Med Chem (2000) 0.75

[The calculation of "pA2 equivalents", a way to determine the anti-secretagogous potentials in non-anesthetized dog (author's transl)]. Gastroenterol Clin Biol (1978) 0.75

[Determination of the precision in the expression of a D E 50 of anticholinergic activity on isolated guinea pig ileum]. Ann Pharm Fr (1973) 0.75

Mechanisms of anti-bronchoconstrictive effects of eprozinol. II. In vivo studies on the guinea pig. Pharmacology (1981) 0.75

In vitro calcium antagonistic and antioxidant effects of Org 13061 and its enantiomers, new potential antiatherosclerotic compounds. Fundam Clin Pharmacol (1997) 0.75

Sugar derivatives of indolamines. Part IV: dissociation between the affinity of desoxyribulo-serotonin towards D and M type tryptaminergic receptors and study of its effect on platelet functions. Thromb Res (1979) 0.75

[Comparative activity in the unanesthetized rabbit, of nicergoline and papaverine adenylate and 5-pyridoxal phosphate on local cerebral blood flow]. Therapie (1979) 0.75

[Derivatives of 2,3,4,5,-tetrahydro-1H-pyrido-(3,2-b)azepine and 2,3,4,5-tetrahydro-1H-pyrido(2,3-b)azepine and their corresponding lactams. II. Synthesis and pharmacologic study of their psychotropic activity]. Farmaco Sci (1979) 0.75